Unlocking Potential Harnessing Mrna Technology

According to the Canadian Cancer Society, rare cancers make up around 20 percent of new cancer cases in Canada. Learn how ...

The

Lecture Title: Safety Profiles of COVID-19 Vaccines Presented in Session 3: Current Applications for Infectious Diseases: Clinical ...

Speakers: -Helen Fletcher, professor in immunology, London School of Hygiene and Tropical Medicine -Dr. Jerome Kim, director ...

At Pfizer, we have only begun to

So

Here at Pfizer, we're performing research with

Lecture Title: Clinical Update on

Lecture Title: Polyvalent Vaccines Presented in Session 4: Future Applications of the

NSW Premier Gladys Berejiklian says the state will be taking steps to make it a centre for ongoing

Lecture Title: Development of Universal Influenza Vaccines Using Nucleoside-Modified

... supporting this multilateral effort on the

We talked to David Bentley, co-director of the

Learn about the

The

The Pfizer and Moderna vaccines have been integral to the U.S. inoculating roughly 160 million people against COVID-19.

Not only has the

Improving greatly.

By

COVID-19 vaccines are just the tip of the iceberg for what